1722 - In vivo Activity of Imipenem/XNW4107 Human-Simulated Regimen against Serine Carbapenemase-Producing Acinetobacter baumannii and Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Andrew J. Fratoni, PharmD

Associate Director, Clinical and Laboratory Studies
Hartford Hospital
Hartford, Connecticut, United States

AB

Angela Berry, PharmD

Infectious Disease Pharmacotherapy Fellow
Hartford Hospital
Hartford, Connecticut, United States
HY

Haitao Yuan, PhD

Evopoint Biosciences Co., Ltd
Beijing, Beijing, China
XL

Xiao Liu, PhD

Evopoint Biosciences Co., Ltd
Beijing, Beijing, China
XC

Xi Chen, PhD

Evopoint Biosciences Co., Ltd
Beijing, Beijing, China
YW

Yuchuan Wu, PhD

Evopoint Biosciences Co., Ltd
Beijing, Beijing, China
DN

David P. Nicolau, PharmD

Director
Hartford Hospital
Hartford, Connecticut, United States
Kamilia Abdelraouf, PhD

Associate Director
Hartford Hospital
Hartofrd, CT, United States